Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection
- PMID: 825470
- PMCID: PMC415475
- DOI: 10.1128/iai.14.4.942-947.1976
Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection
Abstract
Antibody to Pseudomonas aeruginosa exotoxin was detected in human sera by using a cytotoxicity-neutralization assay. Serum antitoxin was present in high titer in all 14 patients who recovered from serious pseudomonas infections (log2 of 50% neutralization titer, mean +/- standard deviation = 6.0 +/- 1.2). In contrast, serum antitoxin was present in lower titer in four of seven patients with fatal pseudomonas infections (3.3 +/- 2.7, P less than 0.005), in 3 of 7 patients with non-pseudomonas infections (1.4 +/- 0.6 P less than 0.001), and in 6 of 14 normal control subjects (2.0 +/- 1.3, P less than 0.001). Fourfold or greater serum antitoxin rises were demonstrated in two survivors of acute infections, and toxin-neutralizing activity was associated with the immunoglobulin G fraction of human sera. Immunization of rabbits with purified exotoxin also induced high antitoxin titers.
Similar articles
-
Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.J Clin Microbiol. 1977 Jul;6(1):58-61. doi: 10.1128/jcm.6.1.58-61.1977. J Clin Microbiol. 1977. PMID: 407250 Free PMC article.
-
Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.J Infect Dis. 1973 Oct;128(4):520-6. doi: 10.1093/infdis/128.4.520. J Infect Dis. 1973. PMID: 4200593 No abstract available.
-
Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients.J Clin Microbiol. 1983 Sep;18(3):457-62. doi: 10.1128/jcm.18.3.457-462.1983. J Clin Microbiol. 1983. PMID: 6415090 Free PMC article.
-
Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.J Clin Microbiol. 1982 Jun;15(6):1054-8. doi: 10.1128/jcm.15.6.1054-1058.1982. J Clin Microbiol. 1982. PMID: 6809785 Free PMC article.
-
[Antibodies against Pseudomonas aeruginosa toxin in preparations of normal human immunoglobulin].Zh Mikrobiol Epidemiol Immunobiol. 1983 Jun;(6):100-3. Zh Mikrobiol Epidemiol Immunobiol. 1983. PMID: 6412489 Russian.
Cited by
-
Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A.Infect Immun. 1986 Jun;52(3):756-62. doi: 10.1128/iai.52.3.756-762.1986. Infect Immun. 1986. PMID: 2423458 Free PMC article.
-
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.Infect Immun. 1982 Jun;36(3):1223-8. doi: 10.1128/iai.36.3.1223-1228.1982. Infect Immun. 1982. PMID: 6807846 Free PMC article.
-
Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A: biological, chemical, and immunochemical studies.Infect Immun. 1981 May;32(2):759-68. doi: 10.1128/iai.32.2.759-768.1981. Infect Immun. 1981. PMID: 6265363 Free PMC article.
-
Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa.BMC Infect Dis. 2021 Mar 24;21(1):300. doi: 10.1186/s12879-021-05969-0. BMC Infect Dis. 2021. PMID: 33761869 Free PMC article.
-
[Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].Klin Wochenschr. 1985 Jun 3;63(11):490-8. doi: 10.1007/BF01747978. Klin Wochenschr. 1985. PMID: 3925219 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources